SCHEMBL2960138

SCHEMBL2960138

CC(C)(C)OC(=O)Nc1cc(Cl)c(C(=O)O)c(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA9 Q16790 2/20 0.41
CYP17A1 P05093 2/20 0.40
ATR Q13535 1/20 0.40
CA2 P00918 1/20 0.39
MAPKAPK2 P49137 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
PSMB8 P28062 1/20 0.38
NAMPT P43490 1/20 0.38
TOP2A P11388 1/20 0.38
TOP2B Q02880 1/20 0.38
MAP4K4 O95819 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
POLB P06746 1/20 0.38
HSP90AA1 P07900 1/20 0.37
HSP90AB1 P08238 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL879382 0.87 ATR (0.47) CA12CA1CA9CYP17A1ATR
SCHEMBL8571236 0.86 CA12 (0.43) CA12CA1CA9CYP17A1ATR
SCHEMBL24449312 0.85 CA12 (0.45) CA12CA1CA9CYP17A1ATR
SCHEMBL282268 0.85 DHODH (0.45) CA12CA1CA9CYP17A1ATR
SCHEMBL4213410 0.83 MAPKAPK2 (0.43) CA12CA1CA9CYP17A1ATR
SCHEMBL8569699 0.82 TAS1R3 (0.46) CA12CA1CA9CYP17A1ATR
SCHEMBL22451793 0.82 CA12 (0.40) CA12CA1CA9CYP17A1PTGDR2
SCHEMBL17629762 0.82 RARA (0.43) CA12CA1CA9CYP17A1PSMB8
SCHEMBL4697609 0.81 CA12 (0.46) CA12CA1CA9CYP17A1ATR
SCHEMBL793197 0.81 ATR (0.42) CA12CA1CA9ATRCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7759388-B2 Phenylalanine derivatives AJINOMOTO CO., INC. (JP) 2010-07-20 US disclosed
US-20090048236-A1 NEW PHENYLALANINE DERIVATIVES AJINOMOTO CO. INC (JP) 2009-02-19 US disclosed
US-7452905-B2 Phenylalanine derivatives AJINOMOTO CO., INC. (JP) 2008-11-18 US disclosed
EP-1323711-B1 NOVEL PHENYLALANINE DERIVATIVES AJINOMOTO KK (JP) 2006-11-15 EP disclosed
US-20030220318-A1 New phenylalanine derivatives AJINOMOTO CO. INC (JP) 2003-11-27 US disclosed
EP-1323711-A1 NOVEL PHENYLALANINE DERIVATIVES Ajinomoto Co., Inc. (JP) 2003-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220318-A1 New phenylalanine derivatives VCAM1, PAH, ICAM1 CA12 4675/4885CA1 4367/4885CA9 4203/4885
US-20090048236-A1 NEW PHENYLALANINE DERIVATIVES ITGB4, VCAM1, ITGA4 CA12 4555/4885CA1 4316/4885CA9 3783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.